Eli Lilly's innovation and pipeline diversification support long-term growth, despite patent risks and competition. Read more ...
For 2026, the plan features significantly lower out-of-pocket costs for members who use the plan’s “narrow network” that ...
Leaders at the U.S. Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli ...
Dec 12 (Reuters) - The European Medicines Agency's committee on Friday recommended extending the use of Eli Lilly's ...
The pharmaceutical giant Eli Lilly has once again raised the bar in the highly competitive obesity treatment market. New clinical trial data for its experime ...
Current health news highlights U.S. senators urging action on a bird flu vaccine amid a poultry crisis, booming weight-loss drug markets, a significant IPO by Lumexa Imaging, and the impact of U.S.
Eli Lilly said on Thursday its next-generation obesity drug helped patients lose an average of 28.7% of their weight in a ...
FDA may expedite approval timeline for Eli Lilly's weight-loss treatment, potentially moving decision date to late March from ...
The European Medicines Agency's committee on Friday recommended extending the use of Eli Lilly's blockbuster drug Mounjaro ...
Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli Lilly's experimental ...
Senate rejects dueling healthcare bills as ACA deadline looms; Calls to pull COVID vaccines get louder but the data reiterates safety profile; Zealand Pharma’s GLP-1 strategy.
The company also said earlier this week it will drop $6 billion on a new manufacturing facility in Huntsville, Alabama.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback